Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Just Group first-half profits drop 23%

(Sharecast News) - Retirement products provider Just Group posted a 23% drop in first-half underlying operating profit on Thursday, citing lower new business margins on lower sales. In the six months to 30 June, underlying operating profit declined to £192m from £249m. This was "driven by lower new business margins on lower sales, offset by higher recurring in-force profit", it said.

Adjusted pre-tax profit fell to £217m from £267m and retirement income sales declined to £2.2bn from £2.5bn in the same period a year earlier.

Just Group said defined benefit sales were down 13% to £1.6bn but have outperformed a slower market that is expected to bounce back strongly in the second half.

The company, which agreed last month to be bought by Canada's Brookfield Wealth Solutions for £2.4bn, said new business margins remain "attractive" at 7.5%, down from 9% in the first half of 2024 and 8.4% in the second half.

The reduction was put down to tighter spreads, increased competition, business mix and lower volumes.

Chief executive David Richardson said: "I am pleased with the performance in the first six months of 2025, particularly given the quieter level of transactions in the DB market at the beginning of the year. With multiple opportunities available to us, the second half of the year is already shaping up to deliver a strong six months of sales for the group.

"We remain disciplined, continue to execute strongly and are investing in the business to support our future growth. We are putting all the building blocks in place to build on the substantial progress we've delivered.

"We operate in fundamentally attractive markets, and are confident in our ability to consistently compound value."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.